RBC lifts target to USD 496 for HCA Healthcare stock

Published on 10/15/2026 at 15:02 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Second-quarter revenue was USD 20.23 billion on June 30, 2026. HCA Healthcare stock costs EUR 423.85 on October 15, 2026; NYSE stock gained 2.10 percent.

Analyst view and reporting date

RBC raised its HCA Healthcare target from USD 435.00 to USD 496.00 on October 7, 2026.
Second-quarter revenue reached USD 20.23 billion on June 30, 2026, up 8.70 percent year over year.
HCA Healthcare stock costs EUR 423.85 at Lang & Schwarz on October 15, 2026 at 3:00 p.m. CEST; the NYSE move was plus 2.10 percent on October 14, 2026.
HCA Healthcare will hold its third-quarter earnings call on October 27, 2026.

Draufsicht auf Aktienzertifikat, ISIN-Karte US40412C1018, Stethoskop und Medizinequipment auf Marmor — HCA Healthcare US40412C1018 Flatlay mit Aktienzertifikat ISIN Karte Stethoskop und branchentypischen medizinischen Utensilien, Illustration mit AI erstellt.

RBC raised its HCA Healthcare target from USD 435.00 to USD 496.00 on October 7, 2026, according to Yahoo Finance. The new target is 5.43 percent above HCA Healthcare's NYSE price of USD 470.44 dated October 14, 2026. At 3:00 p.m. CEST on October 15, 2026, the stock was EUR 423.85 at Lang & Schwarz.

Revenue reached USD 20.23 billion

HCA Healthcare's second-quarter revenue reached USD 20.23 billion for the period ended June 30, 2026, up 8.70 percent from the year-ago quarter. Adjusted earnings were USD 7.59 per share, above the USD 7.40 consensus, while revenue exceeded the USD 19.38 billion estimate, according to Investing.com. This combination gives the analyst target a measurable operating backdrop rather than a purely valuation-based signal.

Stock sits below yearly high

The NYSE quote was USD 470.44 on October 14, 2026, inside a 52-week range of USD 353.99 to USD 556.52. The price stood 15.46 percent below the high. Trading volume was 1,081,388 shares, compared with an average of 1,372,334 shares, a 21.21 percent gap.

Valuation and October 27 results

HCA Healthcare had a market capitalization of USD 101.9 billion, a trailing P/E ratio of 15.75 and a dividend yield of 0.01 percent on October 14, 2026. The company announced that its third-quarter earnings call will take place on October 27, 2026, at 10:00 a.m. Eastern time, in an HCA Healthcare announcement dated September 30, 2026.

Comparison with peers

HCA Healthcare (NYSE, USD): plus 2.10 percent, P/E 15.75, market capitalization USD 101.9 billion.
Tenet Healthcare (NYSE, USD): plus 1.76 percent, P/E 10.47, market capitalization USD 21.9 billion.
Universal Health Services (NYSE, USD): plus 3.84 percent, P/E 7.62, market capitalization USD 11.0 billion.

EUR quote at Lang & Schwarz

HCA Healthcare's euro quote of EUR 423.85 at Lang & Schwarz on October 15, 2026 at 3:00 p.m. CEST provides the German-market view, while the latest NYSE session showed a plus 2.10 percent move on October 14, 2026.

The further course of trading is shown by the continuously updated real-time quote of HCA Healthcare stock.